A detailed history of Sapient Capital LLC transactions in Pfizer Inc stock. As of the latest transaction made, Sapient Capital LLC holds 966,911 shares of PFE stock, worth $25.8 Million. This represents 0.57% of its overall portfolio holdings.

Number of Shares
966,911
Previous 953,032 1.46%
Holding current value
$25.8 Million
Previous $26.7 Million 4.94%
% of portfolio
0.57%
Previous 0.56%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

BUY
$27.7 - $31.39 $384,448 - $435,661
13,879 Added 1.46%
966,911 $28 Million
Q2 2024

Jul 15, 2024

BUY
$25.26 - $29.6 $159,996 - $187,486
6,334 Added 0.67%
953,032 $26.7 Million
Q1 2024

Apr 22, 2024

BUY
$25.89 - $29.73 $23 Million - $26.5 Million
890,095 Added 1572.52%
946,698 $26.3 Billion
Q4 2023

Feb 06, 2024

BUY
$26.13 - $33.94 $77,893 - $101,175
2,981 Added 5.56%
56,603 $1.63 Billion
Q4 2023

Jan 29, 2024

BUY
$26.13 - $33.94 $1.4 Million - $1.82 Million
53,622 New
53,622 $1.54 Billion

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Sapient Capital LLC Portfolio

Follow Sapient Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sapient Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sapient Capital LLC with notifications on news.